info@efcni.org

Other content tagged: preterm babies

EFCNI involved in new study on blood transfusions in preterm babies

Most preterm babies admitted to a Neonatal Intensive Care Unit (NICU) receive blood transfusions. Some neonates, however, receive blood transfusions even though these transfusions may not be necessary, cause side effects or even harm. Therefore, the International Neonatal tranSfusion PoInt pREvalence study (INSPIRE) aims to describe the current state and indications for blood transfusions among preterm babies in Europe. Although most preterm babies receive blood transfusions in the NICU, there are no international guidelines that have…
Read more

Maintaining human milk bank services throughout the COVID-19 pandemic

Human Milk Bank (HMB) services have been impacted by the global COVID-19 pandemic. To better understand the impact, a Virtual Communication Network (VCN) was formed to collect data and experiences from HMBs across 35 countries. Every year approx. 800,000 infants receive donor human milk (DHM) worldwide. However, seven pandemic-related vulnerabilities to HMB service provision were identified. The World Health Organization (WHO) recommends donor human milk from milk banks (HMB) as the next best…
Read more

One- and two-year follow-up outcomes of the CARE-ROP study

The CARE-ROP study identified ranibizumab as an effective treatment to control acute retinopathy of prematurity (ROP), an eye disease that affects preterm babies. For 16 preterm children entering the follow-up period, their ophthalmologic- and neurodevelopment was assessed at the one-year and two-year visits post-baseline. The patients’ outcomes of ranibizumab usage are very reassuring regarding long-term safety. Yet, late reactivation of ROP can represent a challenge and calls for regular follow-ups. Retinopathy of prematurity is…
Read more